Cargando…

Prostate cancer as a dedifferentiated organ: androgen receptor, cancer stem cells, and cancer stemness

Cancer progression is characterized and driven by gradual loss of a differentiated phenotype and gain of stem cell-like features. In prostate cancer (PCa), androgen receptor (AR) signaling is important for cancer growth, progression, and emergence of therapy resistance. Targeting the AR signaling ax...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaozhuo, Li, Wen (Jess), Puzanov, Igor, Goodrich, David W., Chatta, Gurkamal, Tang, Dean G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2022
Materias:	Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484140/ https://www.ncbi.nlm.nih.gov/pubmed/35866337 http://dx.doi.org/10.1042/EBC20220003

Ejemplares similares

MicroRNA-34a, Prostate Cancer Stem Cells, and Therapeutic Development
por: Li, Wen (Jess), et al.
Publicado: (2022)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Prostate cancer stem cells: the role of androgen and estrogen receptors
por: Di Zazzo, Erika, et al.
Publicado: (2015)

Thyroid and androgen receptor signaling are antagonized by μ‐Crystallin in prostate cancer
por: Aksoy, Osman, et al.
Publicado: (2020)

Development of Bag-1L as a therapeutic target in androgen receptor-dependent prostate cancer
por: Cato, Laura, et al.
Publicado: (2017)

GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019)

ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
por: Mounir, Zineb, et al.
Publicado: (2016)

A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
por: Liu, Song, et al.
Publicado: (2017)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Androgen Receptor Variants Confer Castration Resistance in Prostate Cancer by Counteracting Antiandrogen-Induced Ferroptosis
por: Sun, Rui, et al.
Publicado: (2023)

Suppression of prostate cancer progression by cancer cell stemness inhibitor napabucasin
por: Zhang, Yiming, et al.
Publicado: (2016)

Revisiting Androgen Receptor Signaling in Breast Cancer
por: Dai, Charles, et al.
Publicado: (2023)

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer
por: Antonarakis, Emmanuel S., et al.
Publicado: (2016)

Correction: A comprehensive analysis of coregulator recruitment, androgen receptor function and gene expression in prostate cancer
por: Liu, Song, et al.
Publicado: (2017)

WNT signaling and cancer stemness
por: Katoh, Masuko, et al.
Publicado: (2022)

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
por: Sugawara, Tatsuo, et al.
Publicado: (2019)

VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer
por: Poulose, Ninu, et al.
Publicado: (2022)

Glutathione S-transferase Pi mediates proliferation of androgen-independent prostate cancer cells
por: Hokaiwado, Naomi, et al.
Publicado: (2008)

Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes
por: Ben-Salem, Salma, et al.
Publicado: (2020)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
por: Gillis, Joanna L, et al.
Publicado: (2021)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
por: Chi, Jen‐Tsan, et al.
Publicado: (2020)

Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2013)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
por: Sell, S
Publicado: (1993)

Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases
por: Varenhorst, Eberhard, et al.
Publicado: (2016)

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
por: Anker, Jonathan F., et al.
Publicado: (2018)

In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma
por: Lvu, Wen, et al.
Publicado: (2020)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation
por: Chua, Chee Wai, et al.
Publicado: (2018)

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Consortium study
por: Ward, James E., et al.
Publicado: (2011)

HbA1c Variability and Cardiovascular Events in Patients with Prostate Cancer Receiving Androgen Deprivation Therapy
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2022)

Effect of Dedifferentiation on Time to Mutation Acquisition in Stem Cell-Driven Cancers
por: Jilkine, Alexandra, et al.
Publicado: (2014)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Isorhamnetin inhibited the proliferation and metastasis of androgen-independent prostate cancer cells by targeting the mitochondrion-dependent intrinsic apoptotic and PI3K/Akt/mTOR pathway
por: Cai, Fangzhen, et al.
Publicado: (2020)

Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis
por: Alpert, Evgenia, et al.
Publicado: (2021)

Role of cancer stem cells in racial disparity in colorectal cancer
por: Farhana, Lulu, et al.
Publicado: (2016)

Susceptibility to SARS‐Cov‐2 infection and risk for severe COVID‐19 in patients with prostate cancer on androgen deprivation therapy
por: Gedeborg, Rolf, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lu88q3qf25qp1qhof4g4rlv4b